Global Adoptive Cellular Immunotherapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
LPI (LP Information)' newest research report, the “Adoptive Cellular Immunotherapy Industry Forecast” looks at past sales and reviews total world Adoptive Cellular Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adoptive Cellular Immunotherapy sales for 2023 through 2029. With Adoptive Cellular Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cellular Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cellular Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adoptive Cellular Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cellular Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cellular Immunotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cellular Immunotherapy.
The global Adoptive Cellular Immunotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adoptive Cellular Immunotherapy players cover Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp and Cell Medica Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cellular Immunotherapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
LPI (LP Information)' newest research report, the “Adoptive Cellular Immunotherapy Industry Forecast” looks at past sales and reviews total world Adoptive Cellular Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Adoptive Cellular Immunotherapy sales for 2023 through 2029. With Adoptive Cellular Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adoptive Cellular Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Adoptive Cellular Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Adoptive Cellular Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Adoptive Cellular Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adoptive Cellular Immunotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adoptive Cellular Immunotherapy.
The global Adoptive Cellular Immunotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Adoptive Cellular Immunotherapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Adoptive Cellular Immunotherapy players cover Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp and Cell Medica Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cellular Immunotherapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- TIL
- LAK
- CAR-T
- TCR-T
- CIK
- NK
- DC
- Other
- Hospital
- Cancer Hospital
- Centers for Disease Control and Prevention
- Rehabilitation Center
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc
- Autolus Therapeutics Plc
- Beijing Immunochina Medical Science & Technology Co Ltd
- Bellicum Pharmaceuticals Inc
- Bristol-Myers Squibb Co
- bluebird bio Inc
- CARsgen Therapeutics Ltd
- Celgene Corp
- Cell Medica Ltd
- Cellular Biomedicine Group Inc
- Celularity Inc
- Celyad SA
- Daiichi Sankyo Co Ltd
- Fosun Pharmaceutical AG
- Gilead Sciences Inc
- Guangzhou Anjie Biomedical Technology Co Ltd
- Hangzhou Converd Co Ltd
- Hebei Senlang Biotechnology Inc Ltd
- HRAIN Biotechnology Co Ltd
- Juno Therapeutics Inc
- Kite Pharma Inc
- Nanjing Legend Biotech Co Ltd
- NantKwest Inc
- Nkarta Inc
- Novartis AG
- Ono Pharmaceutical Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Sorrento Therapeutics Inc
- Takara Bio Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cellular Immunotherapy Market Size 2018-2029
2.1.2 Adoptive Cellular Immunotherapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adoptive Cellular Immunotherapy Segment by Type
2.2.1 TIL
2.2.2 LAK
2.2.3 CAR-T
2.2.4 TCR-T
2.2.5 CIK
2.2.6 NK
2.2.7 DC
2.2.8 Other
2.3 Adoptive Cellular Immunotherapy Market Size by Type
2.3.1 Adoptive Cellular Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
2.4 Adoptive Cellular Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Cancer Hospital
2.4.3 Centers for Disease Control and Prevention
2.4.4 Rehabilitation Center
2.4.5 Other
2.5 Adoptive Cellular Immunotherapy Market Size by Application
2.5.1 Adoptive Cellular Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
3 ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cellular Immunotherapy Market Size Market Share by Players
3.1.1 Global Adoptive Cellular Immunotherapy Revenue by Players (2018-2023)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cellular Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELLULAR IMMUNOTHERAPY BY REGIONS
4.1 Adoptive Cellular Immunotherapy Market Size by Regions (2018-2023)
4.2 Americas Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.3 APAC Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.4 Europe Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adoptive Cellular Immunotherapy Market Size by Country (2018-2023)
5.2 Americas Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
5.3 Americas Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cellular Immunotherapy Market Size by Region (2018-2023)
6.2 APAC Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
6.3 APAC Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cellular Immunotherapy by Country (2018-2023)
7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cellular Immunotherapy by Region (2018-2023)
8.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET FORECAST
10.1 Global Adoptive Cellular Immunotherapy Forecast by Regions (2024-2029)
10.1.1 Global Adoptive Cellular Immunotherapy Forecast by Regions (2024-2029)
10.1.2 Americas Adoptive Cellular Immunotherapy Forecast
10.1.3 APAC Adoptive Cellular Immunotherapy Forecast
10.1.4 Europe Adoptive Cellular Immunotherapy Forecast
10.1.5 Middle East & Africa Adoptive Cellular Immunotherapy Forecast
10.2 Americas Adoptive Cellular Immunotherapy Forecast by Country (2024-2029)
10.2.1 United States Adoptive Cellular Immunotherapy Market Forecast
10.2.2 Canada Adoptive Cellular Immunotherapy Market Forecast
10.2.3 Mexico Adoptive Cellular Immunotherapy Market Forecast
10.2.4 Brazil Adoptive Cellular Immunotherapy Market Forecast
10.3 APAC Adoptive Cellular Immunotherapy Forecast by Region (2024-2029)
10.3.1 China Adoptive Cellular Immunotherapy Market Forecast
10.3.2 Japan Adoptive Cellular Immunotherapy Market Forecast
10.3.3 Korea Adoptive Cellular Immunotherapy Market Forecast
10.3.4 Southeast Asia Adoptive Cellular Immunotherapy Market Forecast
10.3.5 India Adoptive Cellular Immunotherapy Market Forecast
10.3.6 Australia Adoptive Cellular Immunotherapy Market Forecast
10.4 Europe Adoptive Cellular Immunotherapy Forecast by Country (2024-2029)
10.4.1 Germany Adoptive Cellular Immunotherapy Market Forecast
10.4.2 France Adoptive Cellular Immunotherapy Market Forecast
10.4.3 UK Adoptive Cellular Immunotherapy Market Forecast
10.4.4 Italy Adoptive Cellular Immunotherapy Market Forecast
10.4.5 Russia Adoptive Cellular Immunotherapy Market Forecast
10.5 Middle East & Africa Adoptive Cellular Immunotherapy Forecast by Region (2024-2029)
10.5.1 Egypt Adoptive Cellular Immunotherapy Market Forecast
10.5.2 South Africa Adoptive Cellular Immunotherapy Market Forecast
10.5.3 Israel Adoptive Cellular Immunotherapy Market Forecast
10.5.4 Turkey Adoptive Cellular Immunotherapy Market Forecast
10.5.5 GCC Countries Adoptive Cellular Immunotherapy Market Forecast
10.6 Global Adoptive Cellular Immunotherapy Forecast by Type (2024-2029)
10.7 Global Adoptive Cellular Immunotherapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Adoptive Cellular Immunotherapy Product Offered
11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Offered
11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Offered
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Adoptive Cellular Immunotherapy Product Offered
11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Adoptive Cellular Immunotherapy Product Offered
11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Offered
11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Adoptive Cellular Immunotherapy Product Offered
11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Adoptive Cellular Immunotherapy Product Offered
11.12.3 Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Offered
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Offered
11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Offered
11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Adoptive Cellular Immunotherapy Product Offered
11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Adoptive Cellular Immunotherapy Product Offered
11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Adoptive Cellular Immunotherapy Product Offered
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Adoptive Cellular Immunotherapy Product Offered
11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adoptive Cellular Immunotherapy Market Size 2018-2029
2.1.2 Adoptive Cellular Immunotherapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Adoptive Cellular Immunotherapy Segment by Type
2.2.1 TIL
2.2.2 LAK
2.2.3 CAR-T
2.2.4 TCR-T
2.2.5 CIK
2.2.6 NK
2.2.7 DC
2.2.8 Other
2.3 Adoptive Cellular Immunotherapy Market Size by Type
2.3.1 Adoptive Cellular Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
2.4 Adoptive Cellular Immunotherapy Segment by Application
2.4.1 Hospital
2.4.2 Cancer Hospital
2.4.3 Centers for Disease Control and Prevention
2.4.4 Rehabilitation Center
2.4.5 Other
2.5 Adoptive Cellular Immunotherapy Market Size by Application
2.5.1 Adoptive Cellular Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
3 ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Adoptive Cellular Immunotherapy Market Size Market Share by Players
3.1.1 Global Adoptive Cellular Immunotherapy Revenue by Players (2018-2023)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Adoptive Cellular Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELLULAR IMMUNOTHERAPY BY REGIONS
4.1 Adoptive Cellular Immunotherapy Market Size by Regions (2018-2023)
4.2 Americas Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.3 APAC Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.4 Europe Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Adoptive Cellular Immunotherapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Adoptive Cellular Immunotherapy Market Size by Country (2018-2023)
5.2 Americas Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
5.3 Americas Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cellular Immunotherapy Market Size by Region (2018-2023)
6.2 APAC Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
6.3 APAC Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adoptive Cellular Immunotherapy by Country (2018-2023)
7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adoptive Cellular Immunotherapy by Region (2018-2023)
8.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADOPTIVE CELLULAR IMMUNOTHERAPY MARKET FORECAST
10.1 Global Adoptive Cellular Immunotherapy Forecast by Regions (2024-2029)
10.1.1 Global Adoptive Cellular Immunotherapy Forecast by Regions (2024-2029)
10.1.2 Americas Adoptive Cellular Immunotherapy Forecast
10.1.3 APAC Adoptive Cellular Immunotherapy Forecast
10.1.4 Europe Adoptive Cellular Immunotherapy Forecast
10.1.5 Middle East & Africa Adoptive Cellular Immunotherapy Forecast
10.2 Americas Adoptive Cellular Immunotherapy Forecast by Country (2024-2029)
10.2.1 United States Adoptive Cellular Immunotherapy Market Forecast
10.2.2 Canada Adoptive Cellular Immunotherapy Market Forecast
10.2.3 Mexico Adoptive Cellular Immunotherapy Market Forecast
10.2.4 Brazil Adoptive Cellular Immunotherapy Market Forecast
10.3 APAC Adoptive Cellular Immunotherapy Forecast by Region (2024-2029)
10.3.1 China Adoptive Cellular Immunotherapy Market Forecast
10.3.2 Japan Adoptive Cellular Immunotherapy Market Forecast
10.3.3 Korea Adoptive Cellular Immunotherapy Market Forecast
10.3.4 Southeast Asia Adoptive Cellular Immunotherapy Market Forecast
10.3.5 India Adoptive Cellular Immunotherapy Market Forecast
10.3.6 Australia Adoptive Cellular Immunotherapy Market Forecast
10.4 Europe Adoptive Cellular Immunotherapy Forecast by Country (2024-2029)
10.4.1 Germany Adoptive Cellular Immunotherapy Market Forecast
10.4.2 France Adoptive Cellular Immunotherapy Market Forecast
10.4.3 UK Adoptive Cellular Immunotherapy Market Forecast
10.4.4 Italy Adoptive Cellular Immunotherapy Market Forecast
10.4.5 Russia Adoptive Cellular Immunotherapy Market Forecast
10.5 Middle East & Africa Adoptive Cellular Immunotherapy Forecast by Region (2024-2029)
10.5.1 Egypt Adoptive Cellular Immunotherapy Market Forecast
10.5.2 South Africa Adoptive Cellular Immunotherapy Market Forecast
10.5.3 Israel Adoptive Cellular Immunotherapy Market Forecast
10.5.4 Turkey Adoptive Cellular Immunotherapy Market Forecast
10.5.5 GCC Countries Adoptive Cellular Immunotherapy Market Forecast
10.6 Global Adoptive Cellular Immunotherapy Forecast by Type (2024-2029)
10.7 Global Adoptive Cellular Immunotherapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Adoptive Cellular Immunotherapy Product Offered
11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Offered
11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Offered
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Adoptive Cellular Immunotherapy Product Offered
11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Adoptive Cellular Immunotherapy Product Offered
11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Offered
11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Adoptive Cellular Immunotherapy Product Offered
11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Adoptive Cellular Immunotherapy Product Offered
11.12.3 Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Offered
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Offered
11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Offered
11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Adoptive Cellular Immunotherapy Product Offered
11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Adoptive Cellular Immunotherapy Product Offered
11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Adoptive Cellular Immunotherapy Product Offered
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Adoptive Cellular Immunotherapy Product Offered
11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adoptive Cellular Immunotherapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of TIL
Table 3. Major Players of LAK
Table 4. Major Players of CAR-T
Table 5. Major Players of TCR-T
Table 6. Major Players of CIK
Table 7. Major Players of NK
Table 8. Major Players of DC
Table 9. Major Players of Other
Table 10. Adoptive Cellular Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 13. Adoptive Cellular Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 16. Global Adoptive Cellular Immunotherapy Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Adoptive Cellular Immunotherapy Revenue Market Share by Player (2018-2023)
Table 18. Adoptive Cellular Immunotherapy Key Players Head office and Products Offered
Table 19. Adoptive Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Adoptive Cellular Immunotherapy Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Adoptive Cellular Immunotherapy Market Size Market Share by Regions (2018-2023)
Table 24. Global Adoptive Cellular Immunotherapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Adoptive Cellular Immunotherapy Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Adoptive Cellular Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Country (2018-2023)
Table 28. Americas Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 30. Americas Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 32. APAC Adoptive Cellular Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Table 34. APAC Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 36. APAC Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 38. Europe Adoptive Cellular Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Country (2018-2023)
Table 40. Europe Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 42. Europe Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Adoptive Cellular Immunotherapy
Table 51. Key Market Challenges & Risks of Adoptive Cellular Immunotherapy
Table 52. Key Industry Trends of Adoptive Cellular Immunotherapy
Table 53. Global Adoptive Cellular Immunotherapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Adoptive Cellular Immunotherapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Adoptive Cellular Immunotherapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Amgen Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 58. Amgen Inc Adoptive Cellular Immunotherapy Product Offered
Table 59. Amgen Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Amgen Inc Main Business
Table 61. Amgen Inc Latest Developments
Table 62. Autolus Therapeutics Plc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 63. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Offered
Table 64. Autolus Therapeutics Plc Main Business
Table 65. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Autolus Therapeutics Plc Latest Developments
Table 67. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 68. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 69. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 70. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 72. Bellicum Pharmaceuticals Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 73. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Offered
Table 74. Bellicum Pharmaceuticals Inc Main Business
Table 75. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bellicum Pharmaceuticals Inc Latest Developments
Table 77. Bristol-Myers Squibb Co Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 78. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Offered
Table 79. Bristol-Myers Squibb Co Main Business
Table 80. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bristol-Myers Squibb Co Latest Developments
Table 82. bluebird bio Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 83. bluebird bio Inc Adoptive Cellular Immunotherapy Product Offered
Table 84. bluebird bio Inc Main Business
Table 85. bluebird bio Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. bluebird bio Inc Latest Developments
Table 87. CARsgen Therapeutics Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 88. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Offered
Table 89. CARsgen Therapeutics Ltd Main Business
Table 90. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. CARsgen Therapeutics Ltd Latest Developments
Table 92. Celgene Corp Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 93. Celgene Corp Adoptive Cellular Immunotherapy Product Offered
Table 94. Celgene Corp Main Business
Table 95. Celgene Corp Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Celgene Corp Latest Developments
Table 97. Cell Medica Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 98. Cell Medica Ltd Adoptive Cellular Immunotherapy Product Offered
Table 99. Cell Medica Ltd Main Business
Table 100. Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Cell Medica Ltd Latest Developments
Table 102. Cellular Biomedicine Group Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 103. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Offered
Table 104. Cellular Biomedicine Group Inc Main Business
Table 105. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cellular Biomedicine Group Inc Latest Developments
Table 107. Celularity Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 108. Celularity Inc Adoptive Cellular Immunotherapy Product Offered
Table 109. Celularity Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Celularity Inc Main Business
Table 111. Celularity Inc Latest Developments
Table 112. Celyad SA Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 113. Celyad SA Adoptive Cellular Immunotherapy Product Offered
Table 114. Celyad SA Main Business
Table 115. Celyad SA Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Celyad SA Latest Developments
Table 117. Daiichi Sankyo Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 118. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 119. Daiichi Sankyo Co Ltd Main Business
Table 120. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Daiichi Sankyo Co Ltd Latest Developments
Table 122. Fosun Pharmaceutical AG Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 123. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Offered
Table 124. Fosun Pharmaceutical AG Main Business
Table 125. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Fosun Pharmaceutical AG Latest Developments
Table 127. Gilead Sciences Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 128. Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Offered
Table 129. Gilead Sciences Inc Main Business
Table 130. Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Gilead Sciences Inc Latest Developments
Table 132. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 133. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 134. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 135. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 137. Hangzhou Converd Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 138. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 139. Hangzhou Converd Co Ltd Main Business
Table 140. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Hangzhou Converd Co Ltd Latest Developments
Table 142. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 143. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Offered
Table 144. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 145. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 147. HRAIN Biotechnology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 148. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 149. HRAIN Biotechnology Co Ltd Main Business
Table 150. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. HRAIN Biotechnology Co Ltd Latest Developments
Table 152. Juno Therapeutics Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 153. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
Table 154. Juno Therapeutics Inc Main Business
Table 155. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Juno Therapeutics Inc Latest Developments
Table 157. Kite Pharma Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 158. Kite Pharma Inc Adoptive Cellular Immunotherapy Product Offered
Table 159. Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Kite Pharma Inc Main Business
Table 161. Kite Pharma Inc Latest Developments
Table 162. Nanjing Legend Biotech Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 163. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 164. Nanjing Legend Biotech Co Ltd Main Business
Table 165. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Nanjing Legend Biotech Co Ltd Latest Developments
Table 167. NantKwest Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 168. NantKwest Inc Adoptive Cellular Immunotherapy Product Offered
Table 169. NantKwest Inc Main Business
Table 170. NantKwest Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. NantKwest Inc Latest Developments
Table 172. Nkarta Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 173. Nkarta Inc Adoptive Cellular Immunotherapy Product Offered
Table 174. Nkarta Inc Main Business
Table 175. Nkarta Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Nkarta Inc Latest Developments
Table 177. Novartis AG Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 178. Novartis AG Adoptive Cellular Immunotherapy Product Offered
Table 179. Novartis AG Main Business
Table 180. Novartis AG Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Novartis AG Latest Developments
Table 182. Ono Pharmaceutical Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 183. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 184. Ono Pharmaceutical Co Ltd Main Business
Table 185. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Ono Pharmaceutical Co Ltd Latest Developments
Table 187. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 188. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 189. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 190. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 191. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 192. Sorrento Therapeutics Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 193. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
Table 194. Sorrento Therapeutics Inc Main Business
Table 195. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 196. Sorrento Therapeutics Inc Latest Developments
Table 197. Takara Bio Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 198. Takara Bio Inc Adoptive Cellular Immunotherapy Product Offered
Table 199. Takara Bio Inc Main Business
Table 200. Takara Bio Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 201. Takara Bio Inc Latest Developments
Table 1. Adoptive Cellular Immunotherapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of TIL
Table 3. Major Players of LAK
Table 4. Major Players of CAR-T
Table 5. Major Players of TCR-T
Table 6. Major Players of CIK
Table 7. Major Players of NK
Table 8. Major Players of DC
Table 9. Major Players of Other
Table 10. Adoptive Cellular Immunotherapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 12. Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 13. Adoptive Cellular Immunotherapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 14. Global Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 15. Global Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 16. Global Adoptive Cellular Immunotherapy Revenue by Players (2018-2023) & ($ Millions)
Table 17. Global Adoptive Cellular Immunotherapy Revenue Market Share by Player (2018-2023)
Table 18. Adoptive Cellular Immunotherapy Key Players Head office and Products Offered
Table 19. Adoptive Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Adoptive Cellular Immunotherapy Market Size by Regions 2018-2023 & ($ Millions)
Table 23. Global Adoptive Cellular Immunotherapy Market Size Market Share by Regions (2018-2023)
Table 24. Global Adoptive Cellular Immunotherapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 25. Global Adoptive Cellular Immunotherapy Revenue Market Share by Country/Region (2018-2023)
Table 26. Americas Adoptive Cellular Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 27. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Country (2018-2023)
Table 28. Americas Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 30. Americas Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. Americas Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 32. APAC Adoptive Cellular Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 33. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Table 34. APAC Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 36. APAC Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 38. Europe Adoptive Cellular Immunotherapy Market Size by Country (2018-2023) & ($ Millions)
Table 39. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Country (2018-2023)
Table 40. Europe Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 42. Europe Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 44. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Region (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Table 46. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Table 48. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Table 50. Key Market Drivers & Growth Opportunities of Adoptive Cellular Immunotherapy
Table 51. Key Market Challenges & Risks of Adoptive Cellular Immunotherapy
Table 52. Key Industry Trends of Adoptive Cellular Immunotherapy
Table 53. Global Adoptive Cellular Immunotherapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 54. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Regions (2024-2029)
Table 55. Global Adoptive Cellular Immunotherapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 56. Global Adoptive Cellular Immunotherapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 57. Amgen Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 58. Amgen Inc Adoptive Cellular Immunotherapy Product Offered
Table 59. Amgen Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Amgen Inc Main Business
Table 61. Amgen Inc Latest Developments
Table 62. Autolus Therapeutics Plc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 63. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Offered
Table 64. Autolus Therapeutics Plc Main Business
Table 65. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Autolus Therapeutics Plc Latest Developments
Table 67. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 68. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 69. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 70. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 72. Bellicum Pharmaceuticals Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 73. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Offered
Table 74. Bellicum Pharmaceuticals Inc Main Business
Table 75. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Bellicum Pharmaceuticals Inc Latest Developments
Table 77. Bristol-Myers Squibb Co Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 78. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Offered
Table 79. Bristol-Myers Squibb Co Main Business
Table 80. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bristol-Myers Squibb Co Latest Developments
Table 82. bluebird bio Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 83. bluebird bio Inc Adoptive Cellular Immunotherapy Product Offered
Table 84. bluebird bio Inc Main Business
Table 85. bluebird bio Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. bluebird bio Inc Latest Developments
Table 87. CARsgen Therapeutics Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 88. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Offered
Table 89. CARsgen Therapeutics Ltd Main Business
Table 90. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. CARsgen Therapeutics Ltd Latest Developments
Table 92. Celgene Corp Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 93. Celgene Corp Adoptive Cellular Immunotherapy Product Offered
Table 94. Celgene Corp Main Business
Table 95. Celgene Corp Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Celgene Corp Latest Developments
Table 97. Cell Medica Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 98. Cell Medica Ltd Adoptive Cellular Immunotherapy Product Offered
Table 99. Cell Medica Ltd Main Business
Table 100. Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Cell Medica Ltd Latest Developments
Table 102. Cellular Biomedicine Group Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 103. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Offered
Table 104. Cellular Biomedicine Group Inc Main Business
Table 105. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Cellular Biomedicine Group Inc Latest Developments
Table 107. Celularity Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 108. Celularity Inc Adoptive Cellular Immunotherapy Product Offered
Table 109. Celularity Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Celularity Inc Main Business
Table 111. Celularity Inc Latest Developments
Table 112. Celyad SA Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 113. Celyad SA Adoptive Cellular Immunotherapy Product Offered
Table 114. Celyad SA Main Business
Table 115. Celyad SA Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Celyad SA Latest Developments
Table 117. Daiichi Sankyo Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 118. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 119. Daiichi Sankyo Co Ltd Main Business
Table 120. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Daiichi Sankyo Co Ltd Latest Developments
Table 122. Fosun Pharmaceutical AG Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 123. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Offered
Table 124. Fosun Pharmaceutical AG Main Business
Table 125. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. Fosun Pharmaceutical AG Latest Developments
Table 127. Gilead Sciences Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 128. Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Offered
Table 129. Gilead Sciences Inc Main Business
Table 130. Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Gilead Sciences Inc Latest Developments
Table 132. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 133. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 134. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 135. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 137. Hangzhou Converd Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 138. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 139. Hangzhou Converd Co Ltd Main Business
Table 140. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Hangzhou Converd Co Ltd Latest Developments
Table 142. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 143. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Offered
Table 144. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 145. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 147. HRAIN Biotechnology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 148. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 149. HRAIN Biotechnology Co Ltd Main Business
Table 150. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. HRAIN Biotechnology Co Ltd Latest Developments
Table 152. Juno Therapeutics Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 153. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
Table 154. Juno Therapeutics Inc Main Business
Table 155. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Juno Therapeutics Inc Latest Developments
Table 157. Kite Pharma Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 158. Kite Pharma Inc Adoptive Cellular Immunotherapy Product Offered
Table 159. Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Kite Pharma Inc Main Business
Table 161. Kite Pharma Inc Latest Developments
Table 162. Nanjing Legend Biotech Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 163. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 164. Nanjing Legend Biotech Co Ltd Main Business
Table 165. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Nanjing Legend Biotech Co Ltd Latest Developments
Table 167. NantKwest Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 168. NantKwest Inc Adoptive Cellular Immunotherapy Product Offered
Table 169. NantKwest Inc Main Business
Table 170. NantKwest Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. NantKwest Inc Latest Developments
Table 172. Nkarta Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 173. Nkarta Inc Adoptive Cellular Immunotherapy Product Offered
Table 174. Nkarta Inc Main Business
Table 175. Nkarta Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. Nkarta Inc Latest Developments
Table 177. Novartis AG Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 178. Novartis AG Adoptive Cellular Immunotherapy Product Offered
Table 179. Novartis AG Main Business
Table 180. Novartis AG Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 181. Novartis AG Latest Developments
Table 182. Ono Pharmaceutical Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 183. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 184. Ono Pharmaceutical Co Ltd Main Business
Table 185. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 186. Ono Pharmaceutical Co Ltd Latest Developments
Table 187. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 188. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Offered
Table 189. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 190. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 191. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 192. Sorrento Therapeutics Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 193. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Offered
Table 194. Sorrento Therapeutics Inc Main Business
Table 195. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 196. Sorrento Therapeutics Inc Latest Developments
Table 197. Takara Bio Inc Details, Company Type, Adoptive Cellular Immunotherapy Area Served and Its Competitors
Table 198. Takara Bio Inc Adoptive Cellular Immunotherapy Product Offered
Table 199. Takara Bio Inc Main Business
Table 200. Takara Bio Inc Adoptive Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 201. Takara Bio Inc Latest Developments
LIST OF FIGURES
Figure 1. Adoptive Cellular Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cellular Immunotherapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adoptive Cellular Immunotherapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adoptive Cellular Immunotherapy Sales Market Share by Country/Region (2022)
Figure 8. Adoptive Cellular Immunotherapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adoptive Cellular Immunotherapy Market Size Market Share by Type in 2022
Figure 10. Adoptive Cellular Immunotherapy in Hospital
Figure 11. Global Adoptive Cellular Immunotherapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Adoptive Cellular Immunotherapy in Cancer Hospital
Figure 13. Global Adoptive Cellular Immunotherapy Market: Cancer Hospital (2018-2023) & ($ Millions)
Figure 14. Adoptive Cellular Immunotherapy in Centers for Disease Control and Prevention
Figure 15. Global Adoptive Cellular Immunotherapy Market: Centers for Disease Control and Prevention (2018-2023) & ($ Millions)
Figure 16. Adoptive Cellular Immunotherapy in Rehabilitation Center
Figure 17. Global Adoptive Cellular Immunotherapy Market: Rehabilitation Center (2018-2023) & ($ Millions)
Figure 18. Adoptive Cellular Immunotherapy in Other
Figure 19. Global Adoptive Cellular Immunotherapy Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Adoptive Cellular Immunotherapy Market Size Market Share by Application in 2022
Figure 21. Global Adoptive Cellular Immunotherapy Revenue Market Share by Player in 2022
Figure 22. Global Adoptive Cellular Immunotherapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Adoptive Cellular Immunotherapy Value Market Share by Country in 2022
Figure 28. United States Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Region in 2022
Figure 33. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Type in 2022
Figure 34. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Application in 2022
Figure 35. China Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Country in 2022
Figure 42. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 65. China Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 69. India Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 72. France Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Adoptive Cellular Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cellular Immunotherapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Adoptive Cellular Immunotherapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Adoptive Cellular Immunotherapy Sales Market Share by Country/Region (2022)
Figure 8. Adoptive Cellular Immunotherapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Adoptive Cellular Immunotherapy Market Size Market Share by Type in 2022
Figure 10. Adoptive Cellular Immunotherapy in Hospital
Figure 11. Global Adoptive Cellular Immunotherapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Adoptive Cellular Immunotherapy in Cancer Hospital
Figure 13. Global Adoptive Cellular Immunotherapy Market: Cancer Hospital (2018-2023) & ($ Millions)
Figure 14. Adoptive Cellular Immunotherapy in Centers for Disease Control and Prevention
Figure 15. Global Adoptive Cellular Immunotherapy Market: Centers for Disease Control and Prevention (2018-2023) & ($ Millions)
Figure 16. Adoptive Cellular Immunotherapy in Rehabilitation Center
Figure 17. Global Adoptive Cellular Immunotherapy Market: Rehabilitation Center (2018-2023) & ($ Millions)
Figure 18. Adoptive Cellular Immunotherapy in Other
Figure 19. Global Adoptive Cellular Immunotherapy Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Adoptive Cellular Immunotherapy Market Size Market Share by Application in 2022
Figure 21. Global Adoptive Cellular Immunotherapy Revenue Market Share by Player in 2022
Figure 22. Global Adoptive Cellular Immunotherapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Adoptive Cellular Immunotherapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Adoptive Cellular Immunotherapy Value Market Share by Country in 2022
Figure 28. United States Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Region in 2022
Figure 33. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Type in 2022
Figure 34. APAC Adoptive Cellular Immunotherapy Market Size Market Share by Application in 2022
Figure 35. China Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Country in 2022
Figure 42. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Adoptive Cellular Immunotherapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Adoptive Cellular Immunotherapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 65. China Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 69. India Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 72. France Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Adoptive Cellular Immunotherapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Adoptive Cellular Immunotherapy Market Size Market Share Forecast by Application (2024-2029)
